Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-02-14 1:18 pm Purchase | 2022-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | VIKING GLOBAL INVESTORS LP | 3,577,128 9.360% | 700,025![]() (+24.33%) | Filing History |
2023-02-14 1:18 pm Sale | 2022-12-31 | 13G | Coupa Software Incorporated COUP | VIKING GLOBAL INVESTORS LP | 0 0.000% | -4,168,030![]() (Position Closed) | Filing History |
2023-02-14 1:18 pm Sale | 2022-12-31 | 13G | PepGen Inc. PEPG | VIKING GLOBAL INVESTORS LP | 1,544,631 6.500% | -249,292![]() (-13.90%) | Filing History |
2023-02-14 1:18 pm Sale | 2022-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | VIKING GLOBAL INVESTORS LP | 0 0.000% | -2,366,385![]() (Position Closed) | Filing History |
2023-02-14 1:18 pm Sale | 2022-12-31 | 13G | PROCEPT BioRobotics Corporation PRCT | VIKING GLOBAL INVESTORS LP | 0 0.000% | -3,658,892![]() (Position Closed) | Filing History |
2023-02-14 1:17 pm Purchase | 2022-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX | VIKING GLOBAL INVESTORS LP | 4,409,146 7.000% | 1,681,897![]() (+61.67%) | Filing History |
2023-02-14 1:17 pm Sale | 2022-12-31 | 13G | Orion Acquisition Corp. OHPA | VIKING GLOBAL INVESTORS LP | 0 0.000% | -3,669,272![]() (Position Closed) | Filing History |
2022-11-25 1:43 pm Sale | 2022-11-22 | 13D | Frazier Lifesciences Acquisition Corporation FLAC | VIKING GLOBAL INVESTORS LP | 0 0.000% | -3,671,462![]() (Position Closed) | Filing History |
2022-11-10 4:56 pm Unchanged | 2022-11-09 | 13D | Cazoo Group Ltd CZOO | VIKING GLOBAL INVESTORS LP | 30,000 7.300% | 0 (Unchanged) | Filing History |
2022-11-03 5:13 pm Purchase | 2022-11-02 | 13D | Frazier Lifesciences Acquisition Corporation FLAC | VIKING GLOBAL INVESTORS LP | 3,671,462 25.670% | 847,062![]() (+29.99%) | Filing History |
2022-11-02 08:22 am Purchase | 2022-11-01 | 13G | Frazier Lifesciences Acquisition Corporation FLAC | VIKING GLOBAL INVESTORS LP | 2,824,400 19.750% | 2,824,400![]() (New Position) | Filing History |
2022-10-07 5:29 pm Purchase | 2022-09-27 | 13G | Trevi Therapeutics, Inc. TRVI | VIKING GLOBAL INVESTORS LP | 5,984,734 9.990% | 5,984,734![]() (New Position) | Filing History |
2022-09-19 5:08 pm Purchase | 2022-09-07 | 13D | Cazoo Group Ltd CZOO | VIKING GLOBAL INVESTORS LP | 30,000 7.300% | 30,000![]() (New Position) | Filing History |
2022-09-09 9:50 pm Sale | 2022-09-08 | 13G | Amylyx Pharmaceuticals, Inc. AMLX | VIKING GLOBAL INVESTORS LP | 5,770,536 9.900% | -1,400,000![]() (-19.52%) | Filing History |
2022-07-01 5:00 pm Purchase | 2022-06-28 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | VIKING GLOBAL INVESTORS LP | 2,877,103 9.700% | 1,600,725![]() (+125.41%) | Filing History |
2022-06-10 4:15 pm Purchase | 2022-05-31 | 13G | Celldex Therapeutics, Inc. CLDX | VIKING GLOBAL INVESTORS LP | 2,366,385 5.100% | 2,366,385![]() (New Position) | Filing History |
2022-05-20 4:15 pm Purchase | 2022-05-10 | 13G | PepGen Inc. PEPG | VIKING GLOBAL INVESTORS LP | 1,793,923 8.000% | 1,793,923![]() (New Position) | Filing History |
2022-04-14 5:09 pm Purchase | 2022-04-04 | 13G | Standard BioTools Inc. LAB | VIKING GLOBAL INVESTORS LP | 8,103,527 9.500% | 8,103,527![]() (New Position) | Filing History |
2022-03-22 5:18 pm Sale | 2022-03-18 | 13G | PROCEPT BioRobotics Corporation PRCT | VIKING GLOBAL INVESTORS LP | 3,658,892 8.400% | -1,249,000![]() (-25.45%) | Filing History |
2022-03-04 5:21 pm Sale | 2022-03-02 | 13D | Ginkgo Bioworks Holdings, Inc. DNA | VIKING GLOBAL INVESTORS LP | 1,276,379 4.990% | -6,297,196![]() (-83.15%) | Filing History |